Skip to main content
OpenTrials

Clinical trial condition

Neurodegenerative Diseases

Explore clinical trials studying Neurodegenerative Diseases. Study availability and eligibility vary by location and protocol.

9,146 public trials 1,794 recruiting studies
Refine in advanced search Browse all conditions

Neurodegenerative Diseases trial results

Recruiting

A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia

NCT05849662

Conditions
Bone Marrow Diseases, CBL Syndrome, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Phoenix Children's Hospital Phoenix, Arizona, United States
  • Children's Hospital Los Angeles Los Angeles, California, United States
  • University of California San Francisco San Francisco, California, United States
  • Children's Hospital of Colorado Denver, Colorado, United States
View all 21 locations
View Trial Details
Recruiting

An Open-Label Study of CTI-1601 in Subjects With Friedreich's Ataxia

NCT06447025

Conditions
Brain Diseases, Central Nervous System Diseases, Cerebellar Diseases, +11 more
Locations
  • University of California Los Angeles Los Angeles, California, United States
  • Fixel Institute for Neurological Disease, University of Florida Health Gainesville, Florida, United States
  • Morsani Center for Advanced Health Care, University of South Florida Health Tampa, Florida, United States
  • University of Iowa Iowa City, Iowa, United States
View Trial Details
Recruiting

Evaluate the Benefit of Corticoid Sparing in Elderly With Generalized AntiRAch Myasthenia Gravis Treated With IV or SC Efgartigimod

NCT07072988

Conditions
Autoimmune Diseases, Autoimmune Diseases of the Nervous System, Immune System Diseases, +11 more
Locations
  • CHU de Nice Nice, Alpes-Maritimes, France
  • Hôpital Henri Mondor Créteil, France
  • Hôpital Raymond Pointcarré Garches, France
  • CHU de Grenoble Grenoble, France
View Trial Details
Recruiting

A Study to Find Out How Nusinersen is Processed in the Body When Given Through the ThecaFlex DRx™ System in Adult and Pediatric Participants With Spinal Muscular Atrophy (PIERRE-PK)

NCT06555419

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
Locations
  • Children's Hospital of Orange County Orange, California, United States
  • Stanford University Medical Center | Department of Neurology_Palo Alto Palo Alto, California, United States
  • Ann & Robert H. Lurie Children's Hospital of Chicago Chicago, Illinois, United States
  • Boston Children's Hospital Boston, Massachusetts, United States
View all 21 locations
View Trial Details
Recruiting

A Study to Learn About the Investigational Drug Rinzimetostat (ORIC-944) in Patients With mCRPC Who Were Previously Treated With Abiraterone Acetate (Himalayas-1)

NCT07723248

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +24 more
Locations
  • Urology Specialists of the Carolinas - University Place Charlotte, North Carolina, United States
  • Summit Urology Murray, Utah, United States
  • First Urology PSC Jeffersonville, Indiana, United States
  • Gabrail Cancer Center Research Canton, Ohio, United States
View Trial Details
Recruiting

A Study Evaluating the Effectiveness and Safety of Risdiplam Administered as an Early Intervention in Pediatric Participants With Spinal Muscular Atrophy After Gene Therapy

NCT05861986

Conditions
Central Nervous System Diseases, Motor Neuron Disease, Muscular Atrophy, Spinal, +4 more
Locations
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Children's Hospital of Colorado Aurora, Colorado, United States
  • University of Florida Pediatrics Gainesville, Florida, United States
  • Children's Healthcare of Atlanta Center for Advanced Pediatrics Atlanta, Georgia, United States
View all 16 locations
View Trial Details

Related conditions